Hamps Bio Limited (BOM:544312)
India
· Delayed Price · Currency is INR 42.75
0.00 (0.00%)
At close: May 7, 2025
Hamps Bio Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Operating Revenue | 64.75 | 55.78 | 53.41 | 38.22 | 46.43 |
| Other Revenue | - | - | -0 | - | - |
| Revenue | 64.75 | 55.78 | 53.4 | 38.22 | 46.43 |
| Revenue Growth (YoY) | 16.08% | 4.45% | 39.71% | -17.67% | - |
| Cost of Revenue | 18.12 | 19.05 | 22.71 | 18.7 | 22.48 |
| Gross Profit | 46.64 | 36.73 | 30.69 | 19.53 | 23.95 |
| Selling, General & Admin | 20.56 | 18.06 | 16.99 | 12.97 | 13.83 |
| Other Operating Expenses | 14.31 | 10.01 | 7.55 | 4.57 | 4.64 |
| Operating Expenses | 38.9 | 31.46 | 27.79 | 20.83 | 22.56 |
| Operating Income | 7.74 | 5.28 | 2.9 | -1.3 | 1.39 |
| Interest Expense | -1.43 | -1.71 | -1.87 | -2.56 | -2.69 |
| Interest & Investment Income | 0.07 | 0.03 | 0.03 | 0 | 0 |
| Other Non Operating Income (Expenses) | -0.06 | -0.07 | -0.03 | -0.03 | -0.06 |
| EBT Excluding Unusual Items | 6.31 | 3.53 | 1.04 | -3.89 | -1.36 |
| Gain (Loss) on Sale of Investments | - | 0.01 | - | - | -0.21 |
| Gain (Loss) on Sale of Assets | - | - | - | 0 | - |
| Other Unusual Items | 0.19 | 0.03 | 0.01 | - | - |
| Pretax Income | 6.5 | 3.57 | 1.05 | -2.22 | -1.57 |
| Income Tax Expense | 1.49 | -0.02 | -0.17 | 0.02 | -0.14 |
| Net Income | 5.01 | 3.59 | 1.22 | -2.24 | -1.43 |
| Net Income to Common | 5.01 | 3.59 | 1.22 | -2.24 | -1.43 |
| Net Income Growth | 39.47% | 195.47% | - | - | - |
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 2 |
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 2 |
| Shares Change (YoY) | 10.35% | - | 11.50% | 50.00% | - |
| EPS (Basic) | 1.70 | 1.34 | 0.45 | -0.93 | -0.89 |
| EPS (Diluted) | 1.70 | 1.34 | 0.45 | -0.93 | -0.89 |
| EPS Growth | 26.53% | 197.78% | - | - | - |
| Free Cash Flow | -6.54 | 4 | 0.42 | - | - |
| Free Cash Flow Per Share | -2.21 | 1.50 | 0.16 | - | - |
| Gross Margin | 72.02% | 65.85% | 57.48% | 51.09% | 51.59% |
| Operating Margin | 11.95% | 9.46% | 5.43% | -3.40% | 2.99% |
| Profit Margin | 7.73% | 6.44% | 2.27% | -5.85% | -3.08% |
| Free Cash Flow Margin | -10.09% | 7.18% | 0.78% | - | - |
| EBITDA | 11.77 | 8.66 | 6.15 | 1.98 | 5.47 |
| EBITDA Margin | 18.18% | 15.53% | 11.52% | 5.19% | 11.79% |
| D&A For EBITDA | 4.04 | 3.39 | 3.25 | 3.28 | 4.09 |
| EBIT | 7.74 | 5.28 | 2.9 | -1.3 | 1.39 |
| EBIT Margin | 11.95% | 9.46% | 5.43% | -3.40% | 2.99% |
| Effective Tax Rate | 22.96% | - | - | - | - |
| Revenue as Reported | 65.01 | 55.85 | 53.45 | 39.9 | 46.43 |
| Advertising Expenses | - | - | - | 0.11 | 0.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.